NKTR
NASDAQ · Pharmaceuticals
Nektar Therapeutics
$81.89
-1.48 (-1.78%)
Open$84.94
Previous Close$83.37
Day High$84.94
Day Low$80.91
52W High$109.00
52W Low$7.99
Volume—
Avg Volume871.3K
Market Cap2.71B
P/E Ratio—
EPS$-9.81
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
-48.4% upside
Current
$81.89
$81.89
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 105.29M | 124.86M | 246.52M |
| Net Income | -312,793,524 | -333,824,465 | 56.66M |
| Profit Margin | -297.1% | -282.2% | 23.0% |
| EBITDA | -264,443,584 | -297,902,768 | 106.98M |
| Free Cash Flow | — | — | 45.61M |
| Rev Growth | -15.7% | -15.7% | +15.2% |
| Debt/Equity | 0.70 | 0.70 | 0.88 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |